The project includes a new technology research center at Boston University and support for scientists around the world.
Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”
“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote.
Results of the trial, which included more than 11,000 patients, were published in the New England Journal of Medicine.
Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.
When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.
The researchers compared hospitalized COVID-19 patients with influenza patients treated in 2018.
The protein was designed to prevent cell death through the disruption of two specific Kv2.1 channels.
The analysis, published in Stroke, gathered data from two massive patient registries in China.
Approximately one in four stroke survivors are affected by disabling anxiety, but there are currently no specific guidelines in place to help these individuals. Could telemedicine be the answer?
A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.
The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020.